In classical phenylketonuria, the absence of liver phenylalanine (Phe) p-hydroxylase results in a high level of Phe in the blood and excretion of abnormal aromatic acid metabolites in the urine (seefig). Unless treated from early infancy by a low Phe diet, progressive intellectual deterioration usually occurs. With the introduction of more sensitive screening procedures (Medical Research Council working party on phenylketonuria, 1968) , not only are infants with classical phenylketonuria detected, but also a whole spectrum of children with hyperphenylalaninaemia, the significance of which is largely unknown (Bickel, 1970) . This raises many problems, including whether or not dietary treatment should be used in these atypical patients.
Children born to women with untreated phenylketonuria frequently have multiple abnormalities including severe mental retardation (Yu and O'Halloran, 1970) , even though they do not have phenylketonuria. With successful treatment, affected girls of normal intelligence are just reaching the age of marriage, and they will require dietary treatment during pregnancy in an attempt to protect the foetus from high levels of Phe and its metabolites in the maternal circulation. Since Phe deficiency of itself is harmful and can cause brain damage, dietary treatment presents problems (Pitt, 1967) .
With these considerations in mind, a more detailed knowledge of the metabolism of Phe both in children and in the human foetus would appear essential to a fuller understanding of the problems involved. Only a few assays on Phe p-hydroxylase and the pteridine cofactor in the human subject Received for publication 12 (Kaufman, 1958; Justice, O'Flynn, and Hsia, 1967; Jakubovic, 1971) Agreement between duplicates within individual enzyme assays was usually excellent. The variation in the phenylalanine hydroxylase assay was usually nil, but occasionally variations of between 0 1 and 0-5 fluorimeter units were found. These are so small that no significant differences can be deduced from the standard graphs. Duplicates in the tyrosine transaminase assay never varied more than 0-01 optical density units. This produces almost negligible differences in the activity: for example, 11 8 instead of 11 -6 ,umoles pHPPA per min per g protein in liver from the female foetus aged 17 weeks. Duplicates in the phenylalanine transaminase assay were also excellent except in subjects K.F., R.S., and D.L. where a variation of 0-01 in optical density caused activities to vary from 49to53,46-5to53-5,and 103 to 109 ,umoles PPA per 10 min per g protein respectively.
Mean results for these three subjects are given in table II. Since aromatic alpha-ketoacid reductase activities are based on a rate of change of optical density, the occasional optical density value that fell outside the straight line could be ignored, and duplicates were all in good agreement.
Opportunities for studying the reproducibility of enzyme assays over several days were severely limited by the small amount of material available, but some indications that reproducibility was fairly good can be seen in table I, which sets out the activities of some specimens during long periods of storage.
Results of the enzyme assays are set out in tables II and III.
Discussion
The concentrations of enzymes were similar in male and female foetuses and apart from Phe p-hydroxylase showed no change with age. The results did suggest that Phe p-hydroxylase might decrease in activity as the male foetuses became older, but until more data are available this finding is inconclusive. Whereas the mean activity for Phe p-hydroxylase in children was 29-2 FLmole per hr per g protein, it was only 14-7 in the foetal liver. Low activity of Phe p-hydroxylase was observed by Jakubovic (1971) in the livers of seven human foetuses aged 11 to 20 weeks, but though both cofactor and reductase were demonstrated no detailed investigations were performed and no adult tissues were included for comparison. There exists, therefore, a diminished but still fairly active system for the conversion of Phe to tyrosine in the foetus. The system is a complex one involving a pteridine cofactor and dihydropteridine reductase, in addition to the Phe p-hydroxylase. The cofactor and dihydropteridine reductase were measured in foetal rat liver by Brenneman and Kaufman (1965) , who found less activity than in the adult rat, whereas the hydroxylase activity was not diminished at all. Although Kenney and Kretchmer (1959) reported that the cofactor and dihydropteridine reductase were present in the foetal rat, they found that Phe p-hydroxylase activity was somewhat lower than in the adult. Recent work by McGee, Greengard, and Knox (1972) supports the latter finding. We are now studying the activities of the cofactor and dihydropteridine reductase in human liver, and the additional data should give a clearer picture of the foetal enzyme system in man.
The activities of the two aminotransferases, particularly the tyrosine: alpha-ketoglutarate enzyme, were much lower in the foetus than in the child. It has been known for some time that amino acid concentrations in the foetal liver (Ryan and Carver, 1966) and circulation (eg, Crumpler, Dent, and Lindan, 1950) are much higher than those in the maternal liver and circulation and this could well be a reflection of the relative inability of the foetal amino-transferases to metabolize the amino acids further. Foetal rat liver is also deficient in tyrosine aminotransferase activity (Sereni, Kenney, and Kretchmer, 1959) . It is possible that a number of the other aminotransferases in foetal liver are also somewhat inactive, although the tyrosine enzyme does appear to be particularly late maturing. Our results suggest that dietary control of the intake during pregnancy in the woman with phenylketonuria will have to be strict if high levels of Phe in the foetus are to be avoided.
Four of the boys (R.L., S.J., J.L., and C.O.) had very high phenylalanine aminotransferase activities and of these C.O. also had an abnormally raised tyrosine aminotransferase activity. Since R.L., S.J., and C.O. also had very high serum GOT and GPT activities, these phenylalanine aminotransferase activities should probably not be regarded as normal. If these four values are omitted from the calculation of the mean activity, it becomes 68 ± 40 umole per 10 min per g protein which corresponds more closely with that of 77 ± 36-6 obtained for the livers from girls.
Neither the present study nor the reported work of Zannoni (1966, 1968) have elucidated the reason for the non-linearity of the change of substrate concentration with time in the assay for aromatic alpha-ketoacid reductase. The activities in the present work are based, as are those of Weber and Zannoni (1966) on the initial rate of disappearance of NADH. The results show that the enzyme is quite active in the foetus (about 65 % of the activity in the child) unlike the activities of the two transaminases.
This study has provided values for some liver enzymes involved in the metabolism of Phe by the foetus and the child. It suffers from the inevitable limitation that all the children were ill and liver biopsy was performed for this reason, but none of them had phenylketonuria and the data provide more valid reference values than would be obtained from studies in animals. Such information may eventually help to elucidate those patients at present considered to have 'hyperphenylalaninaemia' or 'atypical' phenylketonuria.
